Cannabis Law Report

FEBRUARY 23, 2020

The Observer— Complete CBD Oil Guide 2020. CBD Oil Guide 2020. When studies started on cannabinoids, it was found that the body makes a similar substance called endogenous cannabinoids (endocannabinoids). The FDA has recently approved a drug, Epidiolex, to be used as a treatment for epilepsy in children.

Oil 66

Oil CBD Blood Pressure Hemp 66

Cannabis Law Report

OCTOBER 8, 2021

Cannabis Terapeutica reports… Sicily Region and medical cannabis: the mobilization of the Medical Cannabis Patients Committee . “Epilepsy is one of the most frequent neurological diseases,” the report reads. “30% 30% -40% of newly diagnosed patients have difficulty controlling seizures.

Epilepsy 52

Epilepsy Chronic Pain Patients Treatment 52

Veriheal

MARCH 31, 2023

Study Analyzes Cannabis’ Effects on Tourettes Patients A new study published in the journal Cannabis and Cannabinoid Research looked at how medical cannabis could improve the lives of those with Tourettes syndrome. The study enlisted the help of 70 patients with Tourettes. Let’s dive into this week’s cannanews.

Legalization 52

Legalization Chronic Pain Decriminalization Patients 52

Canna Care Docs

SEPTEMBER 18, 2020

Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication. Patients may purchase medical cannabis in oil-based preparations such as lozenges, capsules, and vape pens. Can a Qualifying Patient Grow Cannabis in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

SpeedWeed

APRIL 2, 2021

The legacy of Charlotte Figi, the young Colorado girl whose struggle with epilepsy made CBD known worldwide, will be remembered next week with a benefit concert taking place in her honor. She had a rare form of epilepsy known as Dravet syndrome that caused dozens or even hundreds of seizures per day. She was the catalyst.

Events 52

Events Epilepsy Cannabinoids Treatment 52

Veriheal

JANUARY 15, 2021

On December 14th, 2020, Irish lawmaker Gino Kenny tweeted great news for the country of Ireland. Gino Kenny TD (@Ginosocialist) December 14, 2020. So does that mean that there is no access to THC for patients in the country? This legislation outlines the requirements for certain patients to have access to the MCAP.

Legalization 57

Legalization Therapy Access Legislation 57

Puff Puff Post

JANUARY 1, 2020

Cancer patients suffer not only from cancer, but the damaging effects of treatment. Doctors prescribe various forms of opiods to cancer patients for pain. At other times cannabis treats the pain of cancer patients better. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Veriheal

DECEMBER 28, 2021

Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. The year 2020 served as a major stepping stone for the North American medical cannabis market which, by that point, was already well-established.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists. topiramate.

CBD 98

CBD THC Conditions Medicine 98

MassRoots

MAY 12, 2020

As a beacon of hope for patients in Georgia, an executive director has finally been appointed by the Access to Medical Cannabis Commission to oversee the next stages of development for the state’s medical marijuana program. In five years of program development, patients still have no way to legally purchase the oil within state lines.

Oil 53

Oil Programs Access Patients 53

Puff Puff Post

JANUARY 1, 2020

Cancer patients suffer not only from cancer, but the damaging effects of treatment. Doctors prescribe various forms of opiods to cancer patients for pain. At other times cannabis treats the pain of cancer patients better. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JANUARY 15, 2020

million Series A funding round in 2019, Cannaray has announced the fulfilment of its first UK patient prescription as the company continues to grow, becoming one of UK’s largest Medical Cannabis and CBD company. . Following a £7.8 Cannaray today announces the fulfilment of its first Medical Cannabis prescription in the UK.

CBD 64

CBD Epilepsy Chronic Pain Treatment 64

The Cannigma

AUGUST 26, 2021

percent), according to the United Nations World Drug Report for 2020.In In addition, a survey published in July 2020 found that 41% of Australians support cannabis legalization, and 37% are opposed. A doctor who applies to the TGA on behalf of a patient must provide a clinical justification.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Canna Care Docs

DECEMBER 16, 2020

Between the pandemic and the political climate, 2020 hasn’t exactly been a walk in the park. Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). What is medical marijuana? Nausea and vomiting.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

The Cannigma

MAY 19, 2021

This was notoriously reflected in the 2020 arrest of a Japanese man and woman for speaking positively about using cannabis in social media posts. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. What marijuana products are allowed in Japan?

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

JUNE 1, 2022

Millions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving. These amounts represent frequently consumed dosages: up to 150mg/day over the counter; and up to 1500mg/day for conditions such as epilepsy, pain, sleep disorders and anxiety. More info at [link].

CBD 52

CBD Blood Pressure Sleep Concentrates 52

The Cannigma

AUGUST 29, 2021

to 4.2%, according to a study published in February, 2020. Even the American Association of Retired Persons (AARP) now supports the use of medical marijuana in states where it is legal and officially calls for more research on the medicinal use of cannabinoids. ? Get your medical card now with The Cannigma Medical.

Blood Pressure 87

Blood Pressure Marijuana Conditions Sleep 87

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Since cannabinoids, including CBD, share metabolic pathways with other drugs, and have similar mechanisms of action with other drugs, the potential for interaction exists. topiramate.

CBD 52

CBD THC Conditions Medicine 52

Veriheal

NOVEMBER 2, 2020

The Australian Department of Health and parliament have not established a list of qualifying conditions, but are currently looking into research for conditions commonly treated with cannabis such as chronic pain, epilepsy, and multiple sclerosis amongst others. This is the largest one-month increase ever reported.

Chronic Pain 52

Chronic Pain Strains Conditions Patients 52

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Doctors and patients had to register on the Compassionate Use Registry , an online database maintained by the Florida Department of Health.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

MARCH 3, 2020

MÜV EXTRACT INHALERS, ORAL SPRAYS, AND TINCTURES | Pensacola, Florida Grand Opening, February 15, 2020. On Feburary 14, 2020, Kristie Henderson of WEAR-TV 3 in Pensacola, Florida, reported on a New medical cannabis dispensary opening in Pensacola. “ (GOAL 2) Striving 110% to be “the best at cultivating patient trust.”

Dispensary 64

Dispensary Patients Cannabis Wellness and Beauty 64

Veriheal

OCTOBER 5, 2020

These compounds mostly include cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) amongst many others such as cannabigerol (CBG). The program requires cannabis patients to have a licensed physician to certify that the individual would benefit from medical cannabis before they can register for it.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

SEPTEMBER 8, 2019

It’s not uncommon for the medical industry to get cannibalized when adult-use marijuana is legalized, because it means patients no longer have to wait for a doctor’s approval and prescription to buy weed. Of course, this production capacity is liable to be bumped up if patient demand merits it. Mexico: $1.02

Pharmaceutical 45

Pharmaceutical Recreational Patients Cannabis 45

Cannabis Law Report

MAY 19, 2022

In the Warning Letters, FDA expresses concern with the use of chemicals to convert other cannabinoids in the plant into delta-8 THC. FDA states it has received 104 reports of adverse events in patients who consumed delta-8 THC products between December 1, 2020 and February 28, 2022. FDA Warning Letters.

THC 52

THC CBD Food Pets 52

Cannabis Law Report

JANUARY 28, 2020

27 January 2020. The different approaches on the legality of cultivation and use of (medical) cannabis in the member states have led to a policy paradox within the European Union, causing complications for patients in several member states. Mondaq Article: [link]. CONTRIBUTOR.

Medicine 59

Medicine Cultivation Research and Development Policy 59

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Substances derived from the cannabis plant include marijuana, hemp, and cannabinoids. Executive Summary.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Project CBD

FEBRUARY 28, 2023

This was somewhat less than the nearly 37% decline seen in 2020. sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. decline from 2020. COVID-19 plus legal uncertainty slowed CBD sales in 2020. Epilepsy Behav. million on these products.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

FEBRUARY 1, 2020

For a Singaporean publication to look at regulated cannabis in this depth and provide a series of comparisons tells us a lot about where this market is heading in the region in the 2020’s. The bill takes effect at the end of January 2020 and will allow adults to grow up to 2 cannabis plants at home and possess up to 50g on their person.

Legalization 59

Legalization Research and Development Recreational Access 59

Cannabis Law Report

DECEMBER 23, 2021

This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. C3 Cannabinoid Compound Company. However, no single cannabinoid drug has received widespread approval in the treatment of pain. However, regulations are constantly shifting.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Conclusions. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

MARCH 12, 2021

But sometimes one unintended consequence of adult-use legalization is that the market no longer caters to medical patients. And he’s looking at it and all these words are coming out, cannabinoids, THC, CBD, ratios, terpenes, and the customer realizes they have no idea what they’re doing. It’s a non-trivial issue.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

MARCH 6, 2020

SAN DIEGO , March 5, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: KLS-13019 has not been reviewed or approved for patient use by the U.S. This is the sixth patent grant that Kannalife has received. “Experts project the European Union market alone to reach over $226 billion in total pharmaceutical sales.”

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

The Cannigma

SEPTEMBER 13, 2021

The cause of legalization in Israel also received an apparent boost back in February, 2020, when then-Prime Minister Benjamin Netanyahu tweeted (at 4:20pm) that he had examined the matter and decided to support the expungement of the records for tens of thousands of Israelis charged with minor cannabis possession charges.

Legalization 97

Legalization Decriminalization Patients Cannabis 97

Cannabis Law Report

SEPTEMBER 1, 2019

I actually produce more natural cannabinoids than the average person – that’s helped me recover from seven strokes,” says Elisabetta Faenza, now CEO of Australian medicinal cannabis company LeafCann. Zaena says she expects LeafCann’s facility to be operational and selling products by late 2020 or early 2021. But not everyone agrees. “I

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Veriheal

JULY 21, 2022

This month, patients will no longer require a medical cannabis card to participate in Virginia’s medical cannabis program. On July 1, the process of procuring pharmaceutical-approved cannabis was simplified for individuals residing across the state, where the first licensed medical marijuana dispensary opened its doors in August 2020.

Access 104

Access Dispensary Patients Programs 104

Cannabis Law Report

NOVEMBER 22, 2019

Arizona regulators will stop issuing physical medical cannabis patient cards as of December 1 and will instead issue documents via email, that can be presented on a mobile phone or printed out. The state expects to issue its first license by the end of November and sales to begin by the end of the first quarter 2020.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45